Status:
ACTIVE_NOT_RECRUITING
Peripheral Artery Disease in Regular Hemodialysis Patients
Lead Sponsor:
Sohag University
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
Brief Summary
Recent studies have reinforced the association between high NLR and PAD in hemodialysis patients. This highlights the need for further studies to confirm its predictive value and determine optimal cut...
Eligibility Criteria
Inclusion
- Adult patients aged ≥18 years.
- Undergoing maintenance hemodialysis for at least 3 months (thrice weekly)
- Able to provide informed consent.
- Willing to undergo clinical and laboratory evaluations, including peripheral vascular assesment
Exclusion
- Active infection or sepsis at the time of evaluation
- .\* Patients who have a sedimentation rate of more than 60 mm/hour
- \*. Known autoimmune or hematologic disorders that may influence leukocyte count.
- Current use of immunosuppressive therapy, corticosteroids, or chemotherapy.5. History of malignancy.6. Patients with incomplete medical records or unable to undergo peripheral vascular assessment.
Key Trial Info
Start Date :
July 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 13 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07179211
Start Date
July 13 2025
End Date
July 13 2026
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag faculty
Sohag, Egypt